Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023
August 14, 2023 08:15 ET
|
Guardion Health Sciences, Inc.
HOUSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer
May 30, 2023 08:00 ET
|
Guardion Health Sciences, Inc.
HOUSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023
May 15, 2023 08:15 ET
|
Guardion Health Sciences, Inc.
HOUSTON, May 15, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022
April 17, 2023 08:15 ET
|
Guardion Health Sciences, Inc.
HOUSTON, April 17, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value
March 06, 2023 08:00 ET
|
Guardion Health Sciences, Inc.
HOUSTON, March 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements
January 24, 2023 16:05 ET
|
Guardion Health Sciences, Inc.
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it has received confirmation from The Nasdaq Stock Market...
Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023
January 06, 2023 16:15 ET
|
Guardion Health Sciences, Inc.
HOUSTON, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it will effect a 1-for-50 reverse split of its common...
Guardion Health Sciences Announces Pricing of Aggregate $4.75 Million Institutional Private Placement of Series C and Series D Redeemable Preferred Stock
November 29, 2022 17:06 ET
|
Guardion Health Sciences, Inc.
HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2022
November 14, 2022 08:25 ET
|
Guardion Health Sciences, Inc.
Viactiv® Generated Net Revenues of Approximately $2.6 Million or 96% of Net Revenues for the Quarter Ended September 30, 2022 Company Announces Program to Evaluate Strategic Alternatives HOUSTON,...
Guardion Health Sciences Announces Clinical Results Indicating that Viactiv® Omega Boost™ Gel Bites Increase Omega-3 Levels in Just 4 weeks
October 06, 2022 08:00 ET
|
Guardion Health Sciences, Inc.
New Viactiv Omega Boost™ Gel Bites Clinically Proven to Increase Omega-3 Levels by 51% in Just 4 Weeks First-Ever Clinically Proven Gel Bites, with a Tasty Fruit Flavor and No Fish Burps, are a...